尽管Cooke & Bieler LP的股份减少,但Kenvue Inc公司在Q4的股票增加了106.6%。 Kenvue Inc. saw its stock rise 106.6% in Q4, despite a stake reduction by Cooke & Bieler LP.

在问题4中,机构投资者调整了在Kenvue Inc.(NYSE:KVUE)的股份,Cooke & Bieler LP在出售48 626股后将所有权减少了1.8%。 In Q4, institutional investors adjusted their stakes in Kenvue Inc. (NYSE:KVUE), with Cooke & Bieler LP reducing ownership by 1.8% after selling 48,626 shares. Kenvue是一家消费者保健公司,其库存在Q4中上升106.6%。 Kenvue, a consumer health company, saw its stock rise 106.6% in Q4. 该公司通过三个部分运作:自我护理、皮肤健康和美容以及基本保健,其品牌如Tylenol和Benadryl。 The firm operates through three segments: Self Care, Skin Health and Beauty, and Essential Health, with brands like Tylenol and Benadryl. Kenvue的市场上限为45.67亿美元,PE比率为45.09,预计今年的EPS为1.14。 Kenvue has a market cap of $45.67 billion, a PE ratio of 45.09, and is forecasted to post 1.14 EPS for the current year.